11-hydroxy-6-methylprogesterone,
HMS Liquifilm,
HMS suspension,
medrysone,
medrysone,
Hydroxymesterone,
Medrifar,
Medrocort,
2668-66-8,
Medritonic,
Visudrisone,
HMS Liquifilm,
6alpha-Methyl-11beta-hydroxyprogesterone,
U-8471,
UNII-D2UFC189XF,
GSH 1043,
NSC-63278,
HMS,
D2UFC189XF,
11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione,
Medriabioptal,
Sedesterol,
Spectramedryn,
Medriusar,
Medroftal,
MLS000028714,
CHEBI:34829,
U 8471,
Medrisone [DCIT],
CPD000058693,
SMR000058693,
Medrysonum [INN-Latin],
Medrisona [INN-Spanish],
DSSTox_CID_25371,
DSSTox_RID_80833,
DSSTox_GSID_45371,
(6S,8S,9S,10R,11S,13S,14S,17S)-17-acetyl-11-hydroxy-6,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one,
Medrysonum,
Medrisona,
Medrisone,
EINECS 220-208-7,
NSC 63278,
11beta-Hydroxy-6alpha-methylprogesterone,
Medrysone (USAN),
6-alpha-Methyl-11-beta-hydroxyprogesterone,
Progesterone, 11beta-hydroxy-6alpha-methyl-,
11-beta-Hydroxy-6-alpha-methylpregn-4-ene-3,20-dione,
Medrysone [USAN:USP:INN],
Prestwick_89,
NCGC00016616-01,
CAS-2668-66-8,
Opera_ID_635,
Prestwick0_000743,
Prestwick1_000743,
Prestwick2_000743,
Prestwick3_000743,
11.beta.-Hydroxy-6.alpha.-methylprogesterone,
6.alpha.-Methyl-11.beta.-hydroxyprogesterone,
AC1L6L4H,
HMS (TN),
SCHEMBL4493,
Pregn-4-ene-3,20-dione, 11-beta-hydroxy-6-alpha-methyl-,
BSPBio_000726,
MLS001076155,
MLS002207230,
MLS002222162,
SPBio_002665,
Pregn-4-ene-3,20-dione, 11-hydroxy-6-methyl-, (6alpha,11beta)-,
11beta-Hydroxy-6alpha-methyl-4-pregnene-3,20-dione,
BPBio1_000800,
GTPL7086,
CHEMBL1201173,
DTXSID6045371,
6-Methyl-11-hydroxyprogesterone,
BCBcMAP01_000088,
11.beta.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione,
HMS1570E08,
HMS2097E08,
HMS2232F13,
HMS3259A22,
HMS3714E08,
HY-B1076,
NSC63278,
ZINC3977945,
Tox21_110526,
2534AH,
AKOS024285179,
Tox21_110526_1,
CCG-220743,
CS-4632,
DB00253,
NC00599,
SMP1_000061,
NCGC00179460-01,
NCGC00179460-03,
SAM002564258,
ST082266,
C14643,
D02289,
668M668,
C-44121,
Progesterone, 11.beta.-hydroxy-6.alpha.-methyl-,
SR-01000721900,
SR-01000721900-3,
BRD-K56515112-001-03-4,
BRD-K56515112-001-21-6,
Pregn-4-ene-3, 11.beta.-hydroxy-6.alpha.-methyl-,
WLN: L E5 B666 OV MUTJ A1 CQ E1 FV1 L1,
Medrysone, United States Pharmacopeia (USP) Reference Standard,
Pregn-4-ene-3, 11-hydroxy-6-methyl-, (6.alpha.,11.beta.)-,
Pregn-4-ene-3,20-dione, 11beta-hydroxy-6alpha-methyl- (8CI),
(1S,2R,8S,10S,11S,14S,15S,17S)-14-acetyl-17-hydroxy-2,8,15-trimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-5-one,
(1S,8S,10S,11S,14S,15S,17S,2R)-14-acetyl-17-hydroxy-2,8,15-trimethyl-5-oxotetr acyclo[8.7.0.0<2,7>.0<11,15>]heptadec-6-ene,
Medrysone [USAN:INN],
D04SFH,
C22H32O3,
CID247839,
C22-H32-O3,
11-beta-hydroxy-6-alpha-methylprogester-one,
Pregn-4-ene-3,20-dione, 11.beta.-hydroxy-6.alpha.-methyl-,
(6-alpha,11-beta)-11-Hydroxy-6-methylpregn-4-ene-3,20-dione,
Pregn-4-ene-3,20-dione, 11-hydroxy-6-methyl-, (6.alpha.,11.beta.)-,